Underserved therapies
Identifying important treatments that may be overlooked because of limited commercial demand or restricted availability.
About ASECA
Essential medicines.
Meaningful access.
Advancing Specialized Essential Care & Access for underserved human and animal patient populations—because every patient matters, even when the market is small.
Who we are
Focused on the therapies others may overlook.
ASECA was founded on a simple belief: no patient should lose access to an important medicine simply because the market is too small to attract the attention of large pharmaceutical companies.
We are a specialty pharmaceutical company dedicated to identifying, developing, and supplying high-quality medicines for underserved patient populations in both human and animal healthcare.
Our focus is on therapies that remain clinically relevant yet are often overlooked due to limited commercial demand, restricted availability, or inconsistent supply. We aim to bridge the gap between clinical necessity and market availability.
Our approach is centered on long-term stewardship of specialty medicines. Rather than pursuing only the largest therapeutic markets, we seek opportunities where our expertise can help important treatments remain available.
Our focus
Where healthcare needs remain significant.
We concentrate on specialty and niche therapies where patient populations may be small, but the need for dependable treatment is real.
Quality & reliability
Building trust through a commitment to pharmaceutical quality, regulatory compliance, and reliable supply.
Human & animal health
Supporting healthcare professionals, patients, veterinarians, and distributors with a patient-centred approach.
For selected specialty injectable products, multidose vial presentations may be used where appropriate to support sustainable low-volume manufacturing, affordability, reduced waste, and accurate dose withdrawal according to individual patient needs.
Partner medicines
Connecting patients with specialist partner therapies.
Alongside its own specialty pharmaceutical activities, ASECA acts as a distributor for medicines from partner companies, with a particular focus on orphan drugs and other therapies serving small or underserved patient populations.
Partner distribution
Extending access beyond our own portfolio.
We work to support the availability of selected partner medications for which dependable access can be especially important. Our distribution focus includes orphan drugs and specialist treatments that may serve patients with rare diseases or otherwise limited treatment options.
Through a quality-conscious, responsible approach to distribution, ASECA aims to help healthcare professionals and supply partners access relevant medicines while respecting applicable regulatory requirements.
Product authentication
Verify your ASECA product.
Enter both unique codes supplied with your product to begin an authentication check.
✓Use the two codes exactly as printed on your product packaging.
If a code is damaged, missing, or does not work, please contact the authorised supplier or manufacturer for assistance.
Our direction
Guided by purpose. Built for the long term.
We work to keep clinically important specialty medicines within reach for the people and animals who need them.
01 / OUR VISION
Expand access to essential therapies.
To become a leading specialty pharmaceutical company recognized for restoring and expanding access to essential therapies for underserved human and animal patient populations.
02 / OUR MISSION
Make overlooked medicines accessible.
To identify, develop, manufacture, and supply high-quality specialty medicines that larger manufacturers often overlook, ensuring that important therapies remain accessible to those who need them.
What guides us
Our values, in every decision.
The principles behind how we approach specialty medicines and the communities they serve.
✓Patient-Centered Access
✓Specialty and Niche Therapeutics
✓Quality and Reliability
✓Innovation in Underserved Markets
✓Long-Term Product Stewardship
✓Commitment to Human and Animal Health
The ASECA commitment
Better access starts by paying attention to what matters.
We believe essential therapies deserve thoughtful stewardship—regardless of the size of the market they serve.
Back to the top ↑